Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity

被引:7
|
作者
Petkov, Petko I. [1 ]
Schultz, Terry W. [2 ]
Donner, E. Maria [3 ,4 ]
Honma, Masamitsu [5 ]
Morita, Takeshi [6 ]
Hamada, Shuichi [7 ]
Wakata, Akihiro [8 ]
Mishima, Masayuki [9 ]
Maniwa, Jiro [10 ]
Todorov, Milen [1 ]
Kaloyanova, Elena [1 ]
Kotov, Stefan [1 ]
Mekenyan, Ovanes G. [1 ]
机构
[1] As Zlatarov Univ, LMC, Burgas, Bulgaria
[2] Univ Tennessee, Coll Vet Med, POB 1071, Knoxville, TN 37996 USA
[3] DuPont Haskell Global Ctr Hlth Sci, Newark, DE USA
[4] DuPont Haskell Global Ctr Environm Sci, Newark, DE USA
[5] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Tokyo, Japan
[6] Natl Inst Hlth Sci, Div Risk Assessment, Tokyo, Japan
[7] LSI Medience Corp, Ibaraki, Japan
[8] Astellas Pharma Inc, Osaka, Japan
[9] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Shizuoka, Japan
[10] Res & Dev AstraZeneca KK, Div Clin Sci, Osaka, Japan
关键词
carcinogenicity; IATA; genotoxicity; OECD Toolbox; TIMES; ARYL-HYDROCARBON RECEPTOR; IN-VITRO; CELL-TRANSFORMATION; COMPUTATIONAL TOXICOLOGY; MICRONUCLEUS TEST; AMES TEST; MUTAGENICITY; CHEMICALS; LIVER; INFORMATION;
D O I
10.1002/jat.3338
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
We investigated the performance of an integrated approach to testing and assessment (IATA), designed to cover different genotoxic mechanisms causing cancer and to replicate measured carcinogenicity data included in a new consolidated database. Genotoxic carcinogenicity was predicted based on positive results from at least two genotoxicity tests: one in vitro and one in vivo (which were associated with mutagenicity categories according to the Globally Harmonized System classification). Substances belonging to double positives mutagenicity categories were assigned to be genotoxic carcinogens. In turn, substances that were positive only in a single mutagenicity test were assigned to be mutagens. Chemicals not classified by the selected genotoxicity endpoints were assigned to be negative genotoxic carcinogens and subsequently evaluated for their capability to elicit non-genotoxic carcinogenicity. However, non-genotoxic carcinogenicity mechanisms were not currently included in the developed IATA. The IATA is docked to the OECD Toolbox and uses measured data for different genotoxicity endpoints when available. Alternatively, the system automatically provides predictions by SAR genotoxicity models using the OASIS Tissue Metabolism Simulator platform. When the developed IATA was tested against the consolidated database, its performance was found to be high, with sensitivity of 74% and specificity of 83%, when measured carcinogenicity data were used along with predictions falling within the models' applicability domains. Performance of the IATA would be slightly changed to a sensitivity of 80% and specificity of 72% when the evaluation by non-genotoxic carcinogenicity mechanisms was taken into account. Copyright (c) 2016 John Wiley & Sons, Ltd. The performance of an integrated approach to testing and assessment (IATA) is investigated, covering different genotoxic mechanisms causing cancer and to replicate measured carcinogenicity data included in a new consolidated database. The IATA is docked to the OECD Toolbox and uses measured data for different genotoxicity endpoints when available. Alternatively, the system automatically provides predictions from structure-activity relationship genotoxicity models. When assigned only within the models' domains, performance of the IATA was high, with sensitivity of 74% and specificity of 83%.
引用
收藏
页码:1536 / 1550
页数:15
相关论文
共 50 条
  • [1] COMPLEMENTARITY OF GENOTOXIC AND NONGENOTOXIC PREDICTORS OF RODENT CARCINOGENICITY
    KITCHIN, KT
    BROWN, JL
    KULKARNI, AP
    [J]. TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS, 1994, 14 (02): : 83 - 100
  • [2] A radial-distribution-function approach for predicting rodent carcinogenicity
    Aliuska Morales Helguera
    Miguel Ángel Cabrera Pérez
    Maykel Pérez González
    [J]. Journal of Molecular Modeling, 2006, 12 : 769 - 780
  • [3] A radial-distribution-function approach for predicting rodent carcinogenicity
    Helguera Morales, Aliuska
    Cabrera Perez, Miguel Angel
    Perez Gonzalez, Maykel
    [J]. JOURNAL OF MOLECULAR MODELING, 2006, 12 (06) : 769 - 780
  • [4] Chances for reducing rodent carcinogenicity testing
    Bode, G.
    van der Laan, J. W.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S39 - S39
  • [5] PREDICTING RODENT CARCINOGENICITY BY IN-VIVO BIOCHEMICAL PARAMETERS
    KITCHIN, KT
    BROWN, JL
    KULKARNI, AP
    [J]. ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS-PART C OF JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH, 1994, 12 (01): : 63 - 88
  • [6] Development of Improved In Silico Models for Predicting Rodent Carcinogenicity
    Stavitskaya, Lidiya
    Kruhlak, Naomi L.
    Cross, Kevin P.
    Minnier, Barbara L.
    Bower, David A.
    Chakravarti, Suman
    Saiakhov, Roustem D.
    Benz, R. Daniel
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2013, 32 (01) : 72 - 72
  • [7] The potential of organ specific toxicity for predicting rodent carcinogenicity
    Lee, YW
    Buchanan, BG
    Klopman, G
    Dimayuga, M
    Rosenkranz, HS
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1996, 358 (01) : 37 - 62
  • [8] Developing an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens for global regulatory purposes
    Jacobs, M. N.
    [J]. TOXICOLOGY LETTERS, 2021, 350 : S32 - S32
  • [9] Assessment of hyperplastic lesions in rodent carcinogenicity studies
    Boorman, G
    Dixon, D
    Elwell, M
    Kerlin, R
    Morton, D
    Peters, T
    Regan, K
    Sullivan, J
    [J]. TOXICOLOGIC PATHOLOGY, 2003, 31 (06) : 709 - 710
  • [10] Chances for reducing rodent carcinogenicity testing of human pharmaceuticals
    Van der Laan, J. W.
    Bode, G.
    Pasanen, M.
    [J]. TOXICOLOGY LETTERS, 2018, 295 : S90 - S91